Clinical value of preoperative circulating tumor DNA before surgery in patients with esophageal squamous cell carcinomaRyota Kobayashi, Yuko Kitagawa, Kohei Nakamura et al.|European Journal of Surgical Oncology|2025Cited by 5
Castration-resistant prostate cancer patient presenting with whole genome doubling with CDK-12 mutationYuto Baba, Mototsugu Oya, Kohei Nakamura et al.|BMC Medical Genomics|2022Cited by 4
ASO Author Reflections: Can Circulating Tumor DNA Guide Individualized Treatment for Patients with Esophageal Squamous Cell Carcinoma?Yosuke Morimoto, Yuko Kitagawa, Satoru Matsuda et al.|Annals of Surgical Oncology|2023Cited by 1
Identifying intense inflammatory subtype of esophageal squamous cell carcinoma using clustering approachSatoru Matsuda, Yuko Kitagawa, Shota Hoshino et al.|General Thoracic and Cardiovascular Surgery|2024Cited by 0
Predictive role of circulating tumor DNA for locally advanced esophageal squamous cell carcinoma before surgery.Ryota Kobayashi, Yuko Kitagawa, Rieko Nakamura et al.|Journal of Clinical Oncology|2025Cited by 0